Aberdeen Scientists Develop Fast Field-Cycling Scanner for Cancer Detection

Scientists in Aberdeen have developed a new medical scanner that improves cancer diagnosis and disease tracking. The technology, called Fast Field-Cycling Imaging (FCI), distinguishes tumour material from healthy tissue more accurately than traditional MRI scanners. Researchers say the system can identify previously undetectable disease and provide diagnostic information that existing scanners cannot capture. This breakthrough matters to investors because it signals growth in medical device innovation and could drive demand for diagnostic equipment in the UK healthcare sector.

How the New Scanner Works

The FCI system uses ultra-low magnetic fields generated by lighter copper reels instead of the large superconducting magnets in traditional MRI scanners. By rapidly changing the magnetic field during a scan, the system extracts different types of information from human tissue. Dr Lionel Broche, the project lead, explained that the technology focuses on what the image reveals about tissue contrast rather than simply adding detail. The system answers questions that MRI cannot, such as whether a tumour is aggressive.

Aberdeen’s Medical Innovation Track Record

The FCI scanner builds on the city’s established history in medical imaging. In 1980, a team at the University of Aberdeen built the world’s first clinical MRI scanner. The new FCI system has already shown effectiveness in producing previously unattainable imaging following stroke, identifying cancer spread and brain tumours. Dr Broche described the technology as a “big step forward” in the medical imaging field and called it a “very powerful tool for research.”

Clinical Applications and Future Growth

The FCI system aims to improve how clinicians detect the earliest signs of declining brain health and cancer progression. The technology provides additional diagnostic information that existing scanners cannot capture, potentially transforming how doctors diagnose diseases and track patient treatments. LotusDx, a Glasgow-founded medtech company, has also opened a research and development laboratory in Aberdeen at ONE BioHub to advance diagnostic testing capabilities in the region.

Final Thoughts

Aberdeen’s FCI scanner represents a significant advance in medical imaging technology that could improve cancer and disease diagnosis. The breakthrough reinforces the city’s position as a centre for healthcare innovation and may attract investment in UK medical device development.

FAQs

Disclaimer:

The content shared by Meyka AI PTY LTD is solely for research and informational purposes.  Meyka is not a financial advisory service, and the information provided should not be considered investment or trading advice.